Edison, NJ, United States of America

Venkatramana M Rao

USPTO Granted Patents = 1 


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Venkatramana M Rao: Innovator in Pharmaceutical Development

Introduction

Venkatramana M Rao, a dedicated inventor based in Edison, NJ, has made significant contributions to the field of pharmaceutical sciences. With a focus on innovative solutions for healthcare, he has been instrumental in developing new treatment methods for critical diseases.

Latest Patents

Venkatramana holds a patent related to crystalline forms of 1-benzoyl-4-[2-[4,7-dimethoxy-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine. This invention includes salts and solvates of these compounds and addresses the formulation of pharmaceutical compositions utilizing the crystalline forms. His work is particularly relevant in the context of treating HIV and/or AIDS, showcasing innovative methods for obtaining these crystalline forms.

Career Highlights

Currently, Venkatramana is associated with Bristol-Myers Squibb Company, a renowned leader in the pharmaceutical industry. His tenure at this prestigious organization underscores his commitment to advancing medical treatments and improving patient outcomes through innovative research and development.

Collaborations

Throughout his career, Venkatramana has collaborated with esteemed colleagues such as Chung-Pin H Chen and Qi Gao. These partnerships highlight the importance of teamwork in scientific advancements and the sharing of knowledge across diverse expertise in the field.

Conclusion

Venkatramana M Rao is a notable inventor whose work in developing pharmaceutical formulations has the potential to make a significant impact on the treatment of HIV and AIDS. His dedication to innovation is a valuable asset to the scientific community, particularly within his role at Bristol-Myers Squibb Company.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…